Mayo Clinic Study Suggests Vitamin D May Reduce Intestinal Inflammation in IBD Patients
A recent study conducted by the Mayo Clinic indicates that Vitamin D supplementation may help reduce intestinal inflammation in patients suffering from inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The research involved 48 participants with diagnosed IBD and confirmed Vitamin D deficiency, who received weekly supplements for a 12-week period. Results showed favorable changes in immune system markers, such as increased immunoglobulin A and decreased immunoglobulin G, alongside improvements in disease activity indices and reduced fecal calprotectin levels. These findings suggest that Vitamin D plays a role in regulating the intestinal immune response and improving tolerance to gut microbiota. However, the study lacked a control group and randomization, prompting researchers to urge caution in interpreting the results. While the outcomes are encouraging, specialists emphasize that Vitamin D should not be taken without medical supervision. Proper dosage depends on individual factors like blood levels, age, and diet. Unsupervised supplementation could be ineffective or lead to adverse effects, highlighting the need for broader, randomized trials to confirm these therapeutic potentials.
Wire timeline
Mayo Clinic Study Suggests Vitamin D May Reduce Intestinal Inflammation in IBD Patients
A recent study conducted by the Mayo Clinic indicates that Vitamin D supplementation may help reduce intestinal inflammation in patients suffering from inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The research involved 48 participants with diagnosed IBD and confirmed Vitamin D deficiency, who received weekly supplements for a 12-week period. Results showed favorable changes in immune system markers, such as increased immunoglobulin A and decreased immunoglobulin G, alongside improvements in disease activity indices and reduced fecal calprotectin levels. These findings suggest that Vitamin D plays a role in regulating the intestinal immune response and improving tolerance to gut microbiota. However, the study lacked a control group and randomization, prompting researchers to urge caution in interpreting the results. While the outcomes are encouraging, specialists emphasize that Vitamin D should not be taken without medical supervision. Proper dosage depends on individual factors like blood levels, age, and diet. Unsupervised supplementation could be ineffective or lead to adverse effects, highlighting the need for broader, randomized trials to confirm these therapeutic potentials.
Clarin.com - Home - Lo último